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About 98% of Cystic Fibrosis males are infertile for a congenital bilateral absence 
of vas deferens (CBAVD) always associated with other clinical manifestations. 
However CBAVD alone, when associated to mutations of CFTR gene, could 
be considered an atypical form of CE For a more complete characterization f 
genotype~henotype correlation, we performed an extended mutational nalysis of 
CFTR gene in a group of 57 patients with obstructive azoospermia. We analyzed 
a preliminary mutation panel, searching 33 most common mutations of CFTR 
gene by the PCR/OLA/SCS procedure (Abbott). So far, as second step of genetic 
characterization weperformed the sequencing of 16 out of 27 CFTR exons (cycle 
sequencing, Applied Biosystems). Our results evidence that in 40.3% of alleles is 
present a classical CFTR mutation, in 15.8% the variant allele (TG)12T5, while in 
7.8% are present he variant racts (TG)llT 5 or (TG)12T 7, the cumulative allelic 
frequency in CBAVD examined being about 64%. In 52.6% (30 subjects) of CBAVD 
patients are present two mutations: in 12 of them (40%) are present two classical 
mutations; in 15 out of 30 (50%) is present one classic mutation associated with 
(TG)12T 5, while in 3 out of 30 (10%) is present one classic mutation associated 
with the variant ract (TG)I 1 T 5. 
In conclusion, the high frequency of mutations and/or variant racts observed shows 
that a consistent fraction of CBAVD (52.6%) is correlated with molecular lesions 
of CFTR gene. 
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Introduction: Clinical variation observed in CF is influenced by genetic and 
environmental f ctors. The genetic factors modulating severity of CF are: CFTR 
mutations as primary determinants and variants of other genes as secondary determi- 
nants (CF modifiers). The common approach to identifying CF modifiers is analysis 
of candidate genes elected on the basis of their relevance to CF pathophysiology. 
Here we present a status report from our Canadian study aiming at identification 
of CF modifier genes by this approach. 
Methods: 90 genes were selected for the study, which belong to various functional 
categories associated with CF-relevant biological processes. 190 polymorphic mark- 
ers (SNPs) were selected for genotyping of CF families (N 1262). Association 
analysis was performed on a subset (-50%) of the cohort for which clinical data 
was reviewed for quality. 
Results and Conclusions: 175 intragenic markers corresponding to 90 genes 
have been completely genotyped. Association analysis identified several statistically 
significant SNPs associated with FEV1%pred. This includes TGFf3 gene variants 
which were reported recently by Drumm et al., 2005. We have also observed 
an adverse effect of the TNF~,(308A) variant and a protective ffect of the 
TNF~,(238A) variant on pulmonary function in CF patients with pancreatic 
insufficiency. The association analysis of all SNPs will be extended to the remaining 
patients for whom quality clinical data will be available. 
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Mutations in the cystic fibrosis transmembrane conductance r gulator (CFTR) gene 
have been found in patients with congenital bilateral absence of the vas deferens 
(CBAVD). The TG12 and T5 alleles produce up to 70% of non-functional CFTR 
protein and are involved in the pathogenesis of CBAVD. 
We aimed at analysing the frequencies of the most common CFTR mutations, the 
TG12 and the T5 loci, in 331 male subjects, including 16 men with obstructive 
azoospermia, 22 with secretory azoospermia, 79 with severe oligoasthenoterato- 
zoospermia (OAT) and 214 with normozoospemia (control group). 
The CFTR mutations and T5 allele were more frequent in men with obstructive 
azoospermia (25% and 18.8% of chromosomes) (P < 0.001 and P < 0.001, X 2 test) 
and with secretory azoospermia (13.6% and 11.4% of chromosomes) (P < 0.001 
and P < 0.05, X 2 test) than in the control group (1.9% and 4.2% of chromosomes). 
The CFTR mutations frequency was not different between men with severe OAT 
and the control group. 
The T5 allele was more frequent in men with severe OAT (8.9% of chromosomes) 
than in the control group (4.2% of chromosomes) (P < 0.05, X 2 test). 
The TG12 T5 haplotype frequency was higher in men with obstructive azoospermia 
(18.8% of chromosomes) and with secretory azoospermia (6.8% of chromosomes) 
than in the control group (1.9% of chromosomes) (P < 0.001, P < 0.05, X 2 test). 
This study supports the involvement ofCFTR mutations in secretory and obstructive 
azoospermia. 
We found a correlation between the appearance of the T5 allele and abnormal 
sperm parameters allowing us to propose that T5 allele contributes also to abnormal 
spermatogenesis or sperm maturation. The (TG)m locus modulate the partial 
penetrance of the T5 allele and the determination f TG repeat number is predictive 
of pathogenic T5 alleles. 
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The pathophysiology of cystic fibrosis (CF) disease is very complex, and CF patients 
with identical CFTR genotype display a variable response to/~ aeruginosa infection. 
We selected CD14 as a candidate gene due to its role as an innate immunity gene. 
CD14 is constitutively expressed as a membrane-bound form on the surface of 
monocytes, macrophages, and neutrophils and as a soluble form in serum. It acts as 
a receptor for several bacterial ligands uch as LPS, peptidoglycans and lipoteichoic 
acid. To determine if CD14 modulates the risk to become colonised with/~ aerug- 
inosa, we examined the CD14 159C/T promoter polymorphism for association 
between/~ aeruginosa positive and P aeruginosa negative siblings selected from 
F508del homozygous sib pairs of the European Cystic Fibrosis Twin and Sibling 
Study [1]. The distribution of alleles and genotypes was compared between pairs and 
another group of unrelated CF individuals who became colonised early (<7 years) or 
late (>14 years) in life. We observed a significant difference in the CD14 159C/T 
genotype distribution comparing cohorts tratified for/~ aeruginosa colonisation and 
onset of chronic colonisation. The data indicates that the CD14 159C/T promoter 
polymorphism influences the risk to become colonised with P aeruginosa. 
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